Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Treated Patients 13 to 30

<< Previous

Bullboard Posts

Next >>

Comment by gebremeskelon Mar 11, 2022 9:45am

450 Views

Post# 34506144

RE:RE:RE:RE:RE:RE:RE:Treated Patients 13 to 30

Thanks everybody for the great posts! This bullboard is getting more readable all the time! Welcome back bencro!

socksnblonds642 wrote: Amen, my sentiments exactly. Data presented when there is compelling data to present. I don't need to see a report that shows a lot of pendig results that just makes me anxious for the next release. An open ended speculative report would be alarming at this point. It's already been said, this next report is very important. We shoud see both results and the efficacy of the new hires.

<< Previous

Bullboard Posts

Next >>

This profitable gold stock is on its way up